Anti-sclerostin antibodies: a new frontier in fragility fractures treatment
Bone fragility is the determinant of the increased risk of minimal trauma fracture and must be treated with a multimodal approach that includes pharmacological therapy, physical exercise, and adequate nutrition. Pharmacological therapy, to date based on the administration of antiresorptive drugs, su...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publishing
2023-09-01
|
| Serie: | Therapeutic Advances in Musculoskeletal Disease |
| Accesso online: | https://doi.org/10.1177/1759720X231197094 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|